Results

Total Results: 1,272 records

Showing results for "medications".
Users also searched for: medication reconciliation

221. Draft Research Plan: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
     January 12, 2023 - prior history of osteoporotic fractures, or have long-term use of systemic corticosteroids or other medications

222. Final Research Plan: Perinatal Depression: Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/perinatal-depression-interventions-to-prevent
     June 01, 2023 - residential/long-term care facilities EDs Study Designs KQ 1: RCTs KQ 2:  RCTs; for medications

223. U.S. Preventive Services Task Force Issues Final Reccomendation on Primary Care Interventions to Prevent Child Maltreatment (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/child-maltreatment-interventions-final-rec-bulletin.pdf
     March 19, 2024 - recommendations about clinical preventive services such as screenings, counseling services, and preventive medications

224. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
     March 15, 2013 - cancer, quality of life, disease transmission   KQ 8 Harms from antiviral medications

225. Final Research Plan: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     September 03, 2015 - Interventions aimed at preventing CVD events (i.e., aspirin, HMG-CoA reductase inhibitors, antihypertension medications

226. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
     September 01, 2019 - In trials, participants typically used risk-reducing medications for 3 to 5 years.

227. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
     September 01, 2019 - In trials, participants typically used risk-reducing medications for 3 to 5 years.

228. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
     August 01, 2022 - persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications … be considered standard care as part of disease management or indicated prior to the use of certain medications … treatment have prompted recommendations of shorter courses and that it be used in combination with other medications … working in high-risk settings, or screening indicated prior to the use of specific immu- nosuppressive medications … treatment regi- mens, including lower doses or shorter durations of isoniazid in com- bination with other medications

229. Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
     May 02, 2023 - persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications … be considered standard care as part of disease management or indicated prior to the use of certain medications … treatment have prompted recommendations of shorter courses and that it be used in combination with other medications … working in high-risk settings, or screening indicated prior to the use of specific immunosuppressive medications … treatment regimens, including lower doses or shorter durations of isoniazid in combination with other medications

230. Archived: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
     May 15, 2012 - risk factors provided independent prognostic value in most studies: history of falls, use of certain medications … (for example, psychoactive medications), and gait and balance impairment 10 . … including history of falling, gait and balance impairments, chronic disease status, and use of psychotropic medications … adaptation or modification of home environment; withdrawal or minimization of psychoactive or other medications

231. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
     July 15, 2007 - Bile acid-binding resins are the only medications approved for treatment of dyslipidemia for children … for cholesterol 3) heart attack, angina, 4) stroke, CVD or PVD or 5) medications for the heart; unknown … for cholesterol 3) heart attack, angina, 4) stroke, CVD or PVD or 5) medications for the heart; unknown … for cholesterol 3) heart attack, angina, 4) stroke, CVD or PVD or 5) medications for the heart; unknown … for cholesterol 3) heart attack, angina, 4) stroke, CVD or PVD or 5) medications for the heart; unknown

232. U.S. Preventive Services Task Force Issues Final Recommendations on Screening and Preventive Interventions for Oral Health (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/oral-health-screening-interventions-final-rec-bullletin.pdf
     November 07, 2023 - recommendations about clinical preventive services such as screenings, counseling services, and preventive medications

233. U.S. Preventive Services Task Force Issues Final Recommendation Statements on Screening for Anxiety, Depression, and Suicide Risk in Children and Adolescents (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/screening-anxiety-depression-suicide-risk-final-rec-bulletin.pdf
     October 11, 2022 - recommendations about clinical preventive services such as screenings, counseling services, and preventive medications

234. U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Skin Cancer: More Research is Needed to Recommend For or Against Screening Adolescents and Adults without Symptoms (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/skin-cancer-screening-final-rec-bulletin.pdf
     April 18, 2023 - recommendations about clinical preventive services such as screenings, counseling services, and preventive medications

235. U.S. Preventive Services Task Force Issues Draft Recommendation on Screening for Skin Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/skin-cancer-screening-bulletin.pdf
     November 21, 2022 - recommendations about clinical preventive services such as screenings, counseling services, and preventive medications

236. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
     January 01, 2016 - reports to Congress, the Task Force identified screening tests, behavioral interventions, and preventive medications … These recommendations include screening tests, counseling about healthful behaviors, and preventive medications … PUBLIC POLICIES ORGANIZATIONAL POLICIES INFORMATION/EDUCATION BEHAVIOR CHANGE COUNSELING PREVENTIVE MEDICATIONS … B *Breast Cancer: Preventive Medications for Women at Increased Risk The USPSTF recommends that clinicians … and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications

237. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
     January 01, 2016 - reports to Congress, the Task Force identified screening tests, behavioral interventions, and preventive medications … These recommendations include screening tests, counseling about healthful behaviors, and preventive medications … PUBLIC POLICIES ORGANIZATIONAL POLICIES INFORMATION/EDUCATION BEHAVIOR CHANGE COUNSELING PREVENTIVE MEDICATIONS … B *Breast Cancer: Preventive Medications for Women at Increased Risk The USPSTF recommends that clinicians … and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications

238. Final Research Plan: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/oral-health-children-adolescents-screening-preventive-interventions
     June 17, 2021 - Preventive interventions: Behavioral counseling/education by a primary care provider Preventive medications

239. Screening for Depression in Children and Adolescents: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kAg43FLUnTjCU5ZNaaHQtW
     March 01, 2016 - primary care–feasible screening tests; and the benefits and harms of treatment with psychotherapy, medications … Medications for the treatment of depression, such as selective serotonin reuptake inhibitors (SSRIs), … combined treatments, as well as studies of the benefits and harms of other treatments (such as non-SSRI medications … are needed that include only children and adolescents with MDD and focus on cur- rent FDA-approved medications … primary care–feasible screening tests; and the benefits and harms of treat- ment with psychotherapy, medications

240. Archived: Evidence Summary: Screening for Multifactorial Dyslipidemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications … Does treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications … No studies meeting the inclusion criteria evaluated the effect of medications on intermediate outcomes … harms of treatment of multifactorial dyslipidemia with lifestyle modifications and/or lipid-lowering medications … Rigorous trials of dietary supplements and medications to reduce concentrations of atherogenic lipids